瑞马唑仑对椎管内麻醉下泌尿外科手术患者术后恢复质量的影响

Objective To explore the application effect of remimazolam in urological surgeries under spinal anesthesia, and to provide evidence-based medical evidence for the optimization of clinical anesthesia plans. Methods Sixty patients who underwent elective spinal anesthesia in the urology department of our hospital from June to December 2024 were selected and randomly divided into the remimazolam group(Group R) and the blank control group(Group C), with 30 patients in each group. The quality of postoperative recovery was evaluated using the Chinese version of the 15-item Quality of Recovery Scale(QoR-15 scale). The core body temperature during the operation was continuously monitored, the incidence of perioperative hypothermia and shivering and severity of shivering were statistically analyzed. Results On the first day after surgery, the QoR-15 score of group R was significantly higher than that of group C(P<0.05), the core body temperatures of group R at 15 minutes(T2) and 30 minutes(T3) after administration were significantly higher than those of group C at the same time points(P<0.05), the incidence of perioperative hypothermia in group R(36.7%) and the incidence of shivering(10.0%) were significantly lower than those in group C(66.7% and 40.0%), and the shivering were mainly mild, without severe shivering(P<0.05). Conclusion Remimazolam can regulate the function of the body temperature regulation center, alleviate anxiety during surgery, reduce stress responses, lower the risk of hypothermia and shivering, improve the quality of postoperative recovery from multiple aspects, and its pharmacokinetic advantages ensure clinical safety. It has significant promotional value.